For decades, women had been told that PCOS (polycystic ovarian syndrome) was just an ovarian disease and that you needed cysts on your ovaries for a diagnosis. One out of every seven women is assumed to have this problem, and at least 70% are completely unaware of it. But on May 12, 2026, the Lancet published a historic, paradigm-shifting consensus paper that officially declared PCOS dead and renamed it Polyendocrine Metabolic Ovarian Syndrome (PMOS).
This is not cosmetic medical semantics. It is a massive victory for women. And even if you’re in menopause, even if you’re in your mid-50s and have been in this room for a long time, this matters to you. Because the old diagnostic framework for PCOS excluded women across the board who didn’t fit a very narrow description. The truth is that metabolic ovarian syndrome is still active even when the ovaries peter out and run out of eggs.
What Was Wrong with the PCOS Diagnosis?
PCOS was considered a localized fertility and ovarian disease affecting just young women. The old criteria required the presence of cysts and in many cases only flagged women who were not ovulating regularly and struggling with infertility. If those two things were not present, you were automatically declined. “That can’t be true,” they’d say.
But the underlying problem was never just about ovaries. It is a profound neuroendocrine and insulin-driven deficit that continues to silently accelerate risks of insulin resistance, pre-diabetes and diabetes, cardiovascular disease, chronic inflammation, and metabolic dysfunction that often leads to abnormal weight gain, weight loss resistance, and a host of other problems. And this continues across your entire lifespan, long into menopause.
For the one in seven to eight women expected to have PMOS, perimenopause is not just a transition. It is a metabolic collision. And these women have always been left out of clinical trials, particularly when it came to looking at PCOS, because the research almost exclusively examined it in the context of fertility.
The Real Physiology: A Polyendocrine Crisis That Starts in the Brain
PMOS is a multi-axis endocrine disorder heavily rooted in the brain, particularly the hypothalamus. Think of the hypothalamus as the director of your show. It takes in information and informs the pituitary (the conductor), which then communicates with your endocrine organs: your thyroid, adrenal glands, ovaries, and metabolic systems like pancreatic function, insulin, and cortisol.
In the hypothalamus, a specialized cluster of neurons called KNDy neurons secrete kisspeptin, neurokinin B, and dynorphin. These three messengers keep the reproductive system balanced. In PMOS, these neurons are fundamentally overactive. They’re yelling instead of whispering, firing way too fast, and accelerating gonadotropin-releasing hormone (GnRH) pulse frequency by up to 40%.
Here’s what that rapid firing does: it hits the pituitary gland and scrambles its output. Think of it this way: the director of the show has had way too much caffeine and is talking so fast that the conductor can’t get the message right. The result is overproduction of luteinizing hormone (LH) while starving the body of follicle-stimulating hormone (FSH). This elevated LH-to-FSH ratio tells the ovarian cells to pump out excess androgens like DHEA, testosterone, and DHT.
At the same time, the lack of FSH traps follicles in an arrested state where they overproduce anti-Mullerian hormone (AMH), which loops back to the brain and makes those KNDy neurons fire even faster. It’s like giving more caffeine to the hypothalamus. A self-reinforcing cycle.
Why Standard Lab Work Misses PMOS in Midlife
Here’s the midlife nuance that makes this so difficult to catch. Excess body weight, especially around the abdomen where women gain it during perimenopause and menopause, completely masks the hormone signature on standard lab tests. Adipose tissue acts as a pituitary brake that blunts LH amplitude. So LH may be elevated but not fluctuating the way it needs to for proper ovarian function.
Your lab work might show completely normal LH and completely normal FSH. To the untrained clinician looking at those labs, they’ll say you don’t have PCOS or PMOS. But underneath that mask, the rapid GnRH firing at the heart of the condition is still beating.
Why? Because women with excess body weight and hyperinsulinemia have insulin taking over as the primary bully. Insulin bypasses all brain signaling and directly stimulates the ovaries to dump testosterone into your system while simultaneously crashing your sex hormone binding globulin (SHBG). Without enough SHBG, you get way too much free testosterone, which further disrupts the LH-to-FSH ratio, drives insulin resistance, and can drive excessive IGF-1 causing more weight gain, hair loss, chin hair growth, acne, and visceral fat storage around the middle.
The Low-Calorie Diet Trap
Here’s where it gets even more frustrating. When you have PMOS and go on an acute, very low-calorie diet, your insulin drops, which releases the pituitary brake. Your luteinizing hormone then paradoxically spikes about one to 1.5-fold. Your underlying neuroendocrine deficit gets unmasked.
So if your standard “eat less, exercise more” advice completely backfires in midlife, your nervous system reads it as a survival crisis and locks down your metabolism. This is where you feel damned if you do, damned if you don’t. This is why calorie restriction doesn’t work the same way for women with this condition.
Dr. Betty’s Personal Story
Dr. Betty Murray shares her own experience with this condition. She was put on birth control relatively young for painful periods and acne. She was always a “curvy girl” who went from being a skinny, scrawny kid to everything exploding in every direction when puberty hit. Weight was always a fight, even in her teens and early 20s. During her bodybuilding years, she sustained herself on about 1,300 calories while lifting heavy six days a week with cardio. That was the only way she could keep the weight off.
When she stopped the pill and got her tubes tied, all kinds of havoc broke out: cystic acne all over her face, hair loss, eyebrow thinning. Functional medicine told her it was her adrenals, her thyroid, estrogen dominance. She took progesterone. It didn’t do anything. She took testosterone and gained 10 extra pounds. What she was uncovering was PMOS running in the background.
She never had massive cysts on her ovaries. She never had abnormal periods (that she could see, because she was on the pill). She asked multiple times if she had PCOS and kept getting told that without ovarian cysts, it couldn’t be that. But everything from the endocrine side looked like it. This started a 10-year fight with her body.
What You Can Do Tomorrow Morning
If this sounds like you, here’s the practical translation:
Get the right labs. If you’re in perimenopause to menopause, your LH and FSH may not reflect the expected ratio, and a clean ovarian ultrasound is no longer necessary for diagnosis. Demand these tests:
- Fasting insulin
- Hemoglobin A1c
- Full sex hormone panel (including all androgens)
- SHBG
- Full thyroid panel (TSH, free T3, free T4, reverse T3, antibodies)
- Continuous glucose monitor data (to see how even healthy foods react differently in you)
Understand that most providers aren’t PMOS-literate. Most medical providers have zero understanding of perimenopause and menopause. That includes endocrinology, gynecology, internal medicine, and family practice. The vast majority who are menopause-literate are not PMOS-literate. The 2026 Lancet consensus should become standard of care, but the average time for that adoption is almost 18 years.
Talk to your provider about GLP-1 agonists. Research on medications like semaglutide and tirzepatide shows they can be particularly effective in perimenopausal and menopausal women with PMOS when coupled with highly personalized hormone replacement therapy. These drugs don’t just help with peripheral insulin sensitivity. The GLP-1 receptors are physically located in the gonadotropin-releasing hormone neurons in the brain. They may actually help quiet that overactive neuroendocrine storm and the feedback loop that causes the malfunction between LH, FSH, insulin, and obesity.
Get tested before hormone replacement. If you have excess androgens, don’t let somebody talk you into more androgens. Testing before and during hormone therapy is essential to make sure levels are adequate and ideal, providing prevention against cardiovascular disease, Alzheimer’s risk, and osteoporosis.
Consider that lower doses may still help. Eli Lilly’s oral tirzepatide doesn’t work as strongly as injectables but is much more affordable (around $149/month cash pay). Having that regulatory hormone at a dose that doesn’t make you nauseous can still help reset what’s happening in the hypothalamus.
It’s Not a Personal Failure. It’s Your Physiology.
If you’ve felt like weight loss resistance and weight gain just got worse during perimenopause and menopause, know that it’s not a personal failure. It’s not you. It’s your physiology, and you’ve been fighting a multi-axis hormonal issue that is fundamentally different from what works for everyone else.
How would your relationship with your body change if you understood that it’s not a lack of willpower? How would you feel if you understood that hormones hiding behind the scenes, many of which we can’t even test for directly, are driving this? It’s a physiology, not a moral failing.
The era of reducing women’s healthcare to “bikini medicine,” where it’s all about ovaries, uterus, and breasts, is over. The renaming of PCOS to Polyendocrine Metabolic Ovarian Syndrome is a monumental boundary in medical history. It proves that your body requires a deep, holistic, multi-system, multi-hormone strategy, especially as you pass through perimenopause and menopause.
You’re your own best advocate. You know your body best, and your intuition is likely right. But you can’t advocate for yourself with out-of-date information. The map has changed completely. If someone has told you otherwise, you’re not crazy. You’re just dealing with a polyendocrine shift, and with the right information, the right laboratory testing, and the right understanding, even in the face of labs that may not be clear, you can feel better. You just need to find the right practitioners who understand not only the hormones but also the metabolic and endocrine impact of what happens when your hormones are in this situation.
This is why we do what we do at Menrva. So we can help women live their best life through perimenopause and menopause and actually close the women’s health research gap at the same time.